J. Liebetanz

发表

The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation.

D. Fabbro, W. Jahnke, T. Meyer, 2005, Structure.

Protein kinases as targets for anticancer agents: from inhibitors to useful drugs.

Bhabatosh Chaudhuri, Doriano Fabbro, Pascal Furet, 2002, Pharmacology & therapeutics.

Amino–acid-type selective isotope labeling of proteins expressed in Baculovirus-infected insect cells useful for NMR studies

W. Jahnke, G. Fendrich, J. Liebetanz, 2003, Journal of biomolecular NMR.

Cdc2-mediated modulation of pp60c-src activity.

N. Lydon, J. Liebetanz, D. Stover, 1994, The Journal of biological chemistry.

Purification and biochemical characterization of non-myristoylated recombinant pp60c-src kinase.

T. Roberts, H. Piwnica-Worms, N. Lydon, 1992, The Biochemical journal.

Imatinib (STI571) resistance in chronic myelogenous leukemia: molecular basis of the underlying mechanisms and potential strategies for treatment.

J. Mestan, D. Fabbro, P. Furet, 2004, Mini reviews in medicinal chemistry.

Improved expression of kinases in Baculovirus-infected insect cells upon addition of specific kinase inhibitors to the culture helpful for structural studies.

R. Schmitz, G. Fendrich, J. Liebetanz, 2007, Protein expression and purification.

In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase.

D. Fabbro, G. Martiny-Baron, J. Brueggen, 2004, Cancer cell.

Extended kinase profile and properties of the protein kinase inhibitor nilotinib.

J. Mestan, D. Fabbro, G. Martiny-Baron, 2010, Biochimica et biophysica acta.

L 3 Differences in the kinase binding modes of imatinib , nilotinib and dasatinib are reflected in Abl transphosphorylation assays

D. Fabbro, S. Grzesiek, S. Cowan-Jacob, 2009 .

Inhibitors of the Abl kinase directed at either the ATP- or myristate-binding site.

Wolfgang Jahnke, Doriano Fabbro, Pascal Furet, 2010, Biochimica et biophysica acta.

Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia

Doriano Fabbro, Pascal Furet, D. Fabbro, 2006, Acta crystallographica. Section D, Biological crystallography.

Src Phosphorylation of the Epidermal Growth Factor Receptor at Novel Sites Mediates Receptor Interaction with Src and P85α (*)

N. Lydon, J. Liebetanz, D. Stover, 1995, The Journal of Biological Chemistry.

Expression and partial characterization of rat protein kinase C‐δ and protein kinase C‐ξ in insect cells using recombinant baculovirus

N. Lydon, J. Liebetanz, E. McGlynn, 1992 .

Purification and biochemical characterization of non-myristoylated recombinant pp 6 Oc-src kinase

T. Roberts, H. Piwnica-Worms, N. Lydon, 2005 .

Expression and partial characterization of rat protein kinase C-delta and protein kinase C-zeta in insect cells using recombinant baculovirus.

D. Fabbro, T. Meyer, N. Lydon, 1992, Journal of cellular biochemistry.

Biological Crystallography Structural Biology Contributions to the Discovery of Drugs to Treat Chronic Myelogenous Leukaemia

D. Fabbro, G. Rummel, P. Furet, 2022 .

Inhibitors of the Abl kinase directed at either the ATP- or myristate-binding site.

J. Mestan, D. Fabbro, W. Jahnke, 2010, Biochimica et biophysica acta.